As it was established that aging is not associated with massive neuronal loss, as was
believed in the mid‐20th Century, scientific interest has addressed the influence of aging on …

Since its discovery over four decades ago, somatostatin (SOM) receives growing scientific
and clinical interest. Being localized in the nervous system in a subset of interneurons …

Kappa opioid receptors (KORs) in the central nervous system have been known to be
important regulators of a variety of psychiatry illnesses, including anxiety and addiction, but …

Introduction Epilepsy, a major neurological disorder affects about 1% of the Indian
population. The discovery of noninvasive strategies for epilepsy presents a challenge for the …

World Health Organization data suggest that stress, depression, and anxiety have a
noticeable prevalence and are becoming some of the most common causes of disability in …

This paper is the thirty-seventh consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2014 …

Epilepsy is a recurring neurological disease caused by the abnormal electrical activity in the
brain. This disease has caused about 50 new cases in 100,000 populations every year with …

Recent studies have suggested oxytocin as a possible drug to treat social deficits caused by
autism spectrum disorder (ASD), but the safety of intranasal oxytocin in autistic patients has …

Stress is a major trigger of seizures in people with epilepsy. Exposure to stress results in the
release of several stress mediators throughout the brain, including the hippocampus, a …

Microdialysis is a sampling technique first introduced in the late 1950s. Although this
technique was originally designed to study endogenous compounds in animal brain, it is …